SG Americas Securities LLC trimmed its position in Waters Co. (NYSE:WAT) by 87.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,713 shares of the medical instruments supplier’s stock after selling 19,225 shares during the quarter. SG Americas Securities LLC’s holdings in Waters were worth $525,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. WP Advisors LLC acquired a new stake in shares of Waters in the 2nd quarter valued at $101,000. Cornerstone Advisors Inc. raised its stake in Waters by 1,651.2% during the 2nd quarter. Cornerstone Advisors Inc. now owns 753 shares of the medical instruments supplier’s stock worth $146,000 after acquiring an additional 710 shares in the last quarter. Ledyard National Bank raised its stake in Waters by 300.0% during the 2nd quarter. Ledyard National Bank now owns 1,200 shares of the medical instruments supplier’s stock worth $232,000 after acquiring an additional 900 shares in the last quarter. Chesapeake Wealth Management acquired a new stake in Waters during the 1st quarter worth $271,000. Finally, Rockefeller Capital Management L.P. acquired a new stake in Waters during the 1st quarter worth $272,000. Institutional investors and hedge funds own 99.29% of the company’s stock.
WAT has been the topic of several research analyst reports. Cleveland Research lowered shares of Waters from a “neutral” rating to an “underperform” rating in a research note on Thursday, June 14th. Zacks Investment Research upgraded shares of Waters from a “sell” rating to a “hold” rating in a research note on Friday, August 17th. Morgan Stanley lifted their price target on shares of Waters from $200.00 to $205.00 and gave the stock an “equal weight” rating in a research note on Friday, July 13th. Bank of America lowered shares of Waters from a “neutral” rating to an “underperform” rating and set a $190.00 price target on the stock. in a research note on Monday, July 16th. Finally, Robert W. Baird lifted their price target on shares of Waters from $201.00 to $212.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 25th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $206.27.
NYSE WAT opened at $196.17 on Monday. The company has a current ratio of 6.58, a quick ratio of 5.95 and a debt-to-equity ratio of 0.58. The firm has a market capitalization of $14.89 billion, a price-to-earnings ratio of 26.19, a price-to-earnings-growth ratio of 2.37 and a beta of 0.96. Waters Co. has a one year low of $177.58 and a one year high of $220.20.
Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, July 24th. The medical instruments supplier reported $1.95 EPS for the quarter, beating analysts’ consensus estimates of $1.92 by $0.03. The company had revenue of $596.20 million for the quarter, compared to analyst estimates of $598.73 million. Waters had a net margin of 2.12% and a return on equity of 27.85%. Waters’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.76 earnings per share. equities analysts anticipate that Waters Co. will post 8.11 earnings per share for the current year.
In other Waters news, SVP Elizabeth B. Rae sold 4,000 shares of Waters stock in a transaction on Monday, August 27th. The shares were sold at an average price of $190.62, for a total value of $762,480.00. Following the transaction, the senior vice president now directly owns 9,443 shares in the company, valued at $1,800,024.66. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.98% of the company’s stock.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Story: NASDAQ Stock Market Explained
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.